Meiosis ‘checkpoint’ sheds light on birth defects

Without a restraining mechanism necessary for a genome's viability, chromosomes can end up irreversibly broken during meiosis, says Andreas Hochwagen. Birth defects, such as Down syndrome can result if the process is disrupted. (Credit: Naberacka/Flickr)

Researchers have identified two enzymes that play a critical role in meiosis—the process of cell division required in reproduction.

The finding could offer new clues to factors that lead to birth defects.

“We have isolated a checkpoint that is necessary for a genome’s viability and for normal development,” says Andreas Hochwagen, an assistant professor of biology at New York University. “Without this restraining mechanism, chromosomes can end up irreversibly broken during meiosis.”


Most cells in an organism contain two sets of chromosomes, one inherited from the mother and the other from the father.

However, sexual reproduction relies on the production of gametes—eggs and sperm—that contain only one set of chromosomes. These are produced through a specialized form of cell division—meiosis.

In this process, maternal and paternal versions of each chromosome pair up and swap sections of their DNA through a process known as homologous recombination—a “reshuffling” that gives rise to chromosomes with new combinations of maternal and paternal genes. This is followed by cell division.

However, in order for normal development to occur, chromosomes must be replicated prior to their reshuffling. The disruption of this process jeopardizes reproduction and can spur a range of birth defects, notably Down syndrome.

For a study published in eLife, researchers sought to determine what coordinates these processes to ensure they occur in proper order. Doing so would offer insights into how deviations from normal functionality could affect fertility and result in birth defects.

Reshuffle coordinator

They examined budding yeast—a model organism in cell biology because its chromosome replication and regulation are similar to that of humans.

Through a series of manipulations, in which the researchers inhibited the activity of individual proteins, they found two enzymes that were necessary for meiosis: Mec1, which is similar to ATR, known to suppress tumors in humans, and DDK, which is a vital coordinator of chromosome reshuffling.

Specifically, they found that Mec1 senses when chromosomes are being replicated and transmits a molecular “wait” signal to DDK.

In this way, Mec1 acts like a traffic cop that allows chromosome replication to finish without interruption, before giving DDK the OK to begin the reshuffling.

Hannah Blitzblau, a researcher at the Whitehead Institute for Biomedical Research, was a co-author on the study, which was funded by grants from the National Institutes of Health, the Charles A King Trust, and the Alexander and Margaret Stewart Trust.

Source: NYU